Papers by Wesley Tong · AgingResearch.News

Scandinavian Cardiovascular Journal6 Sep
A Scandinavian perspective of the projected lifetime cost-effectiveness of rivaroxaban plus aspirin in the COMPASS trial
Computational studyInterventions
Paper